Fluorescein Angiography Market Size Worth $617.4 Million By 2027: Grand View Research, Inc.

SAN FRANCISCO, Aug. 26, 2020 /PRNewswire/ -- The global fluorescein angiography market size is expected to reach USD 617.4 million by the end of 2027, expanding at a CAGR of 2.7%, according to a new report by Grand View Research, Inc. Increasing prevalence of ophthalmic conditions such as macular degeneration and diabetic retinopathy and rapid technological advancements are some of the high impact-rendering market drivers. However, the growing preference for safer and faster alternatives such as OCT and fundus autofluorescence is anticipated to impede market growth during the forecast period.

Key suggestions from the report:

• North America accounted for the largest share in 2019 owing to favorable reimbursement policies, high adoption rate of advanced technologies, and increasing prevalence of diabetic retinopathy
• By product, the market is segmented into devices, disposables, and accessories
• The devices segment captured the largest market size in 2019 and is expected to witness a CAGR of 3.0% over the forecast period
• Availability of hybrid devices and technological advancements such as auto-focus and integration with AI are major factors driving the devices segment
• Based on application, the market is segmented into macular edema, macular degeneration, macular pucker, ocular melanoma, diabetic retinopathy, and others
• Macular degeneration and diabetic retinopathy captured the largest market share in 2019.

Read 131 page research report with ToC on "Fluorescein Angiography Market Size, Share & Trends Analysis Report By Product (Device, Disposables, Accessories), By Technology (Digital, Analog), By Application, By Region, And Segment Forecasts, 2020 - 2027" at: https://www.grandviewresearch.com/industry-analysis/fluorescein-angiography-market

End-users such as hospitals and imaging centers in the country are effectively adopting AI-based fundus cameras for detecting various blindness-causing diseases. For instance, in January 2019, Deqing County hospital in Guangdong Province conducted a free consultation by featuring an AI camera codeveloped by Sun Yat-sen University and Baidu-a multinational technology company in China that offers services, including a search engine platform-to detect ocular fundus diseases. This AI fundus camera is capable of diagnosing glaucoma, diabetic retinopathy, and macular degeneration.

Despite preference of its alternatives, fluorescein angiography is often used as confirmatory test for a wide range of ophthalmic conditions. The technique provides accurate and high quality pictures which help in selecting efficient treatment regimen. In addition, the demand for tradition fluorescein angiography systems is still high in developing countries. This can be attributed to affordability and product availability.

Grand View Research has segmented the global fluorescein angiography market based on product, technology, application, and region:

• Fluorescein Angiography Product Outlook (Revenue, USD Million, 2016 - 2027)
• Device
• Disposables
• Dye
• Film
• Accessories
• Fluorescein Angiography Technology Outlook (Revenue, USD Million, 2016 - 2027)
• Digital
• Analog
• Fluorescein Angiography Application Outlook (Revenue, USD Million, 2016 - 2027)
• Macular edema
• Macular degeneration
• Macular pucker
• Ocular melanoma
• Diabetic retinopathy
• Others
• Fluorescein Angiography Regional Outlook (Revenue, USD Million, 2016 - 2027)
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Asia Pacific
• Japan
• China
• India
• Malaysia
• Thailand
• South Korea
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Qatar
• List of Key Players of Fluorescein Angiography Market
• Carl Zeiss Meditec, Inc.
• NIDEK Co., Ltd.
• Kowa Company Ltd.
• Topcon Medical Systems, Inc.
• Optomed Oy (Ltd.)
• CenterVue SpA
• Canon, Inc.

Find more research reports on Medical Devices Industry, by Grand View Research:

• Angiography Devices Market – The global angiography devices market size was valued at USD 9.8 billion in 2018 and is projected to expand at a CAGR of 6.54% over the forecast period.
• Retinal Imaging Devices Market – The global retinal imaging devices market size was valued at USD 4.3 billion in 2018 and is projected to expand at a CAGR of 6.7% by 2026. Ophthalmic disorders and increasing demand for early diagnostic measures are the factors expected to drive the overall market growth.
• Fundus Cameras Market – The global fundus cameras market size was valued at USD 347.6 million in 2015 and is growing at a CAGR of 6.8% over the forecast period, Attributed to rising incidence of Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), and glaucoma.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter 

View original content:http://www.prnewswire.com/news-releases/fluorescein-angiography-market-size-worth-617-4-million-by-2027-grand-view-research-inc-301118580.html

SOURCE Grand View Research, Inc.